| Literature DB >> 15950465 |
Mark J Bamford1, Michael J Alberti, Nicholas Bailey, Susannah Davies, David K Dean, Alessandra Gaiba, Stephen Garland, John D Harling, David K Jung, Terence A Panchal, Christopher A Parr, Jon G Steadman, Andrew K Takle, James T Townsend, David M Wilson, Jason Witherington.
Abstract
A novel series of imidazo[4,5-c]pyridines bearing a 1,2,5-oxadiazol-3-ylamine functionality has been developed. These are potent inhibitors of mitogen and stress-activated protein kinase-1.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15950465 DOI: 10.1016/j.bmcl.2005.05.021
Source DB: PubMed Journal: Bioorg Med Chem Lett ISSN: 0960-894X Impact factor: 2.823